Thomas McNerney & Partners, Minneapolis, MN
Pete has over 25 years of health care operating and venture capital experience. In addition
to co-founding Thomas, McNerney & Partners, Pete co-founded Coral Ventures in 1992
where he was responsible for health care investing. Pete is currently a board member of
AppTec Laboratory Services, Inc., AxioMed Spine Corporation, Rosedale Medical, Inc.,
Torax Medical Inc and Alliance Medical Corporation. Pete also is a Myocor, Inc. board
observer. He was previously a board member of Aksys, Ltd. (AKSY), Biomira, Inc.
(BIOM), Cerus Corporation (CERS), Endocardial Solutions, Inc. (ECSI sold to STJ) and
Image-Guided Neurologics, Inc. (sold to MDT).
Prior to joining Coral in 1992, Pete was a co-founder and Managing Partner of The
Kensington Group, a firm specializing in providing management services to early stage
companies in the health care field. In 1986, he founded and was Chief Executive Officer of
Memtec North America, a company established to commercialize cross flow membrane
microfiltration technology in North America. Previously, Pete spent 11 years with Baxter
Healthcare Corporation, where he held various general management positions in the U.S.,
Europe, the Middle East and Southeast Asia.
He has served as President of the Minnesota Venture Capital Association and currently
serves on the Board of Trustees of Blue Cross and Blue Shield of Minnesota. A Certified
Public Accountant, Pete received a B.A. from Yale and an M.B.A. from Stanford